Publikace na 2. lékařská fakulta |
2021
Abstrakt
Souhrn s komentářem. Citace: Solerte SB, et al.
Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control, retrospective, observational study. Diabetes care. 2020 Dec; 43(12):2999-3006.